95369 ⎘
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups - in which the condensed system contains three hetero rings Spiro-condensed systems
COMPOUNDS, COMPOSITIONS, AND METHODS
#2NEUROPLASTIGEN MODULATORS FOR THE TREATMENT OF PAIN, ITCH AND NERVE INJURY
#3GLP-1 RECEPTOR AGONISTS AND METHODS OF USE
#4SPIRO COMPOUNDS AND USES THEREOF IN THE FIELD OF MEDICINE
#5AZOLE DERIVATIVES AS SHP2 INHIBITORS
#6GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF
#7COMPOUNDS AND COMPOSITIONS AS SMARCA2/4 DEGRADERS AND USES THEREOF
#8PIPERIDINE CARBOXAMIDE AZAINDANE DERIVATIVE, METHOD FOR PREPARING SAME, AND USE THEREOF
#9SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS
#10GLYCOGEN SYNTHASE KINASE 3 INHIBITORS AND USES THEREOF
#11AZASPIRO WRN INHIBITORS
#12NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS
#13IKZF2 DEGRADERS AND USES THEREOF
#14Method for Production of Spiro-Oxindole and Indoxyl Derivatives of Mitragynine
#15SPIROCYCLIC PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE
#16EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF
#17DIHYDROIMIDAZO-PYRIMIDINONE COMPOUNDS AS LP-PLA2 INHIBITORS AND USE THEREOF
#18PROCESS FOR THE PREPARATION OF A PURE AMORPHOUS FORM OF UBROGEPANT
#19Crystalline form of (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3-pyrrolidin]-1-yl]propan-1-one
#20OPIOID RECEPTOR AGONIST AND METHODS OF USE THEREOF
#21SPIROCYCLIC COMPOUND AS KRAS-G12C INHIBITOR
#22DONOR-ACCEPTOR TYPE THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIALS BASED ON IMIDAZO[1,2-F]PHENANTHRIDINE AND ANALOGUES
#23SPIROTRICYCLE RIPK1 INHIBITORS AND METHODS OF USES THEREOF
#24PYRROLOPYRAZOLE SPIRO COMPOUND
#25BRM Targeting Compounds And Associated Methods Of Use
#26SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#27FUSED RING DERIVATIVE HAVING MGAT-2 INHIBITORY ACTIVITY
#28COMPOUNDS
#29SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS
#30DISPIROPYRROLIDINE DERIVATIVES
#31SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
#32(S)-1-(5-((PYRIDIN-3-YL)THIO)PYRAZIN-2-YL)-4'H,6'H-SPIRO[PIPERIDINE-4,5'-PYRROLO [1,2-B]PYRAZOL]-4'-AMINE DERIVATIVES AND SIMILAR COMPOUNDS AS SHP2 INHIBITORS FOR THE TREATMENT OF E.G. CANCER
#33FABI INHIBITORS FOR GRAM-NEGATIVE PATHOGENS
#34Compounds and Their Use as PDE4 Activators
#35Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#362,3-DIHYDRO-1H-PYRROLO[3,2-B]PYRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#37HETEROCYCLIC INHIBITORS OF EGFR AND/OR HER2, FOR USE IN THE TREATMENT OF CANCER
#38HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME, MANUFACTURING METHOD OF THE SAME AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE
#39METHODS AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY
#40PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER
#41CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT EMITTING DEVICE
#42SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#43KRATOM OPIOID DERIVATIVES FOR THE TREATMENT OF ALCOHOL USE DISORDER
#44SPIRO COMPOUNDS AS INHIBITORS OF KRAS
#45Methods for antagonizing a melanocortin 4 receptor
#46SPIROCYCLIC PIPERIDINE MELANOCORTIN SUBTYPE-2 RECEPTOR (MC2R) ANTAGONISTS AND USES THEREOF
#47NOVEL SPIROPYRROLIDINE DERIVED ANTIVIRAL AGENTS
#48SMARCA INHIBITORS AND USES THEREOF
#49Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-f]phenanthridine and analogues
#50CYCLIN-DEPENDENT KINASE INHIBITORS
#51Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3'-indoline]-2',5(3H)-dione analogues
#52CYCLIN-DEPENDENT KINASE INHIBITORS
#53Melanocortin 4 receptor antagonists and uses thereof
#54SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS BRUTON'S TYROSINE KINASE MODULATORS
#55Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use
#56UREA, AMIDE, AND SUBSTITUTED HETEROARYL COMPOUNDS FOR CBL-B INHIBITION
#57ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
#58Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof
#59Spirocyclic lactams as JAK2 V617F inhibitors
#605,6,7,7a-tetrahydrocyclopenta[f]pyrido[1,2-h][1,7]naphthyridin-11(4bH)-one compounds and methods of use
#61Small molecules active against gram-negative bacteria
#62DISPIROPYRROLIDINE DERIVATIVES
#63SPIRO-CONDENSED PYRROLIDINE DERIVATIVES AS DEUBIQUITYLATING ENZYMES (DUB) INHIBITORS
#64Fused ring derivative having MGAT-2 inhibitory activity
#65MITRAGYNINE ANALOGS AND USES THEREOF
#66Quinolino-pyrrolidin-2-one derivative and application thereof
#67Substituted tricyclic compounds as FGFR inhibitors
#68HETEROCYCLIC COMPOUND FOR USE IN ELECTRONIC DEVICES
#69MNK INHIBITORS AND METHODS RELATED THERETO
#70NMDA RECEPTOR MODULATORS AND USES THEREOF
#71Spiro compounds as inhibitors of KRAS
#72Mitragynine analogs for the treatment of pain, mood disorders and substance use disorders
#73Mitragynine alkaloids as opioid receptor modulators
#74Discovery of novel first in class nature-inspired compounds targeting the mitochondrial function and pharmaceutical composition thereof
#75Methods and compositions for cellular immunotherapy
#76Organic compound, electroluminescent material, and application thereof
#77Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer
#78Compounds
#79NEW SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#80Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues
#81PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS
#82Heterocyclic derivatives useful as SHP2 inhibitors
#83Substituted tricyclic compounds as FGFR inhibitors
#84Fused ring derivative having MGAT-2 inhibitory activity
#85SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF
#86Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors
#87Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-f]phenanthridine and analogues
#88Organic compound and organic electroluminescence device using the same
#89Compound or pharmaceutically acceptable salt thereof
#90Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators
#91Metabotrophic glutamate receptor 5 modulators and methods use thereof
#92Compounds
#93Analogs of vincamine and uses thereof
#94Materials for organic light-emitting devices
#95PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS
#96Inhibitors of RNA guided nucleases and uses thereof
#97MNK INHIBITORS AND METHODS RELATED THERETO
#98Hepatitis B antiviral agents
#99Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#100MK2 inhibitors and uses thereof
#101Small molecules active against gram-negative bacteria
#102METABOTROPHIC GLUTAMATE RECEPTOR 5 MODULATORS AND METHODS USE THEREOF
#103Heterocyclic ring derivatives useful as SHP2 inhibitors
#104SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
#105Substituted polycyclic pyridone derivatives and prodrugs thereof
#106Mitragynine alkaloids as opioid receptor modulators
#107NMDA receptor modulators and uses thereof
#1084-cyano-benzyl carbamimidoylcarbamate derivatives and their use as AOC3 inhibitors
#109COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF
#110Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (DUB) inhibitors
#111Compounds
#112RESPIRATORY SYNCYTIAL VIRUS INHIBITORS
#113Spiropyrazine derivatives as inhibitors of non-apoptotic regulated cell-death
#114Methods and compositions for cellular immunotherapy
#115Donor-acceptor type thermally activated delayed fluorescent materials based on imidazo[1,2-F]phenanthridine and analogues
#116Compounds and methods for treating synovial sarcomas
#117Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators
#118Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties
#119Organic electroluminescent device and manufacturing method thereof
#120Polycyclic compound and organic electroluminescence device including the same
#121Mitragynine analogs and uses thereof
#122Intermediates for preparing CGRP receptor antagonists
#123Substituted polycyclic pyridone derivatives and prodrugs thereof
#124Spiro-isoquinoline-1,4′-piperidine compounds having multimodal activity against pain
#125Compound, preparation method thereof and organic light emitting display device
#126Spiro-lactam NMDA receptor modulators and uses thereof
#127Piperidinone carboxamide azaindane CGRP receptor antagonists
#128MNK INHIBITORS AND METHODS RELATED THERETO
#129Metabotrophic glutamate receptor 5 modulators and methods use thereof
#130Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
#131Inhibitors of the renal outer medullary potassium channel
#1321,9-diazaspiro undecane compounds having multimodal activity against pain
#133Spiro-lactam NMDA receptor modulators and uses thereof
#134Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal cellular proliferation
#135Compound, luminescent material and organic light emitting device using same
#136MNK inhibitors and methods related thereto
#137Isoindolinone inhibitors of phosphatidylinositol 3-kinase
#138Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
#139Compounds
#140Spirocyclic morphinans and use thereof
#141Pyrrolopyrazine-Spirocyclic piperidine amides as modulators of ion channels
#142Substituted tricyclic compounds as FGFR inhibitors
#143Pyridyl piperidines
#144Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators
#145Spiro urea compounds as RSV antiviral compounds
#14610-substituted morphinan hydantoins
#147Piperidinone carboxamide azaindane CGRP receptor antagonists
#148Spiro compound having azafluorene ring structure, light-emitting material, and organic electroluminescent device
#149MATERIALS FOR ORGANIC LIGHT-EMITTING DEVICES
#150Spiro-condensed lactam compounds for organic electroluminescent devices
#151Imidazole derivative used as antiviral agent and use therof in preparation of medicament
#152Spirocyclic hetercycle compounds useful as HIV integrase inhibitors
#153MNK inhibitors and methods related thereto
#154Spiroindoline Antiparasitic Derivatives
#155Metabotrophic glutamate receptor 5 modulators and methods of use thereof
#156MK2 INHIBITORS
#157EphA4 inhibitors as neuroprotective agents
#158Compounds for the treatment of malaria
#159Process for making CGRP receptor antagonists
#160Substituted imidazo[1,2-b]pyrazoles as bruton'S tyrosine kinase modulators
#161Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#162SPIRO[3H-INDOLE-3,2'-PYRROLIDIN]-2(1H)-ONE COMPOUNDS AND DERIVATIVES AS MDM2-P53 INHIBITORS
#163Synthesis of autophagy inducing compound and the uses thereof
#164Inhibitors of the renal outer medullary potassium channel
#165Spiroimidazolone derivative
#166Spiro[3H-indole-3,2′-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
#167MK2 inhibitors and uses thereof
#168Mnk inhibitors and methods related thereto
#169Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
#170Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis C
#171NMDA receptor modulators and uses thereof
#1724-pyridinonetriazine derivatives as HIV integrase inhibitors
#173Quinuclidine, 1-azabicyclo[2.2.1]heptane, 1-azabicyclo [3.2.1]octane, and 1-azabicyclo[3.2.2]nonane compounds as alpha-7 nicotinic acetylcholine receptor ligands
#174Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation
#175RSV antiviral compounds
#176Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators
#177Heterocyclic compound and organic light emitting device using the same
#178Aliphatic spirolactam CGRP receptor antagonists
#179Spirocyclic morphinans and their use
#180Antifibrinolytic compounds
#181Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
#182N1/N2-lactam acetyl-CoA carboxylase inhibitors
#183Process for making CGRP receptor antagonists
#184NMDA receptor modulators and uses thereof
#185Pyridine CGRP receptor antagonists
#186Inhibitors of the renal outer medullary potassium channel
#187Chemical process for preparing spiroindolones and intermediates thereof
#188Process for making CGRP receptor antagonists
#189Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease
#190N1/N2-lactam acetyl-CoA carboxylase inhibitors
#191Substituted pyrrolo[1,2-a]piperazines and pyrrolo[1,2-a][1,4]diazepines as neurokinin 1 receptor antagonists
#192Structural mimetics of proline-rich peptides and use thereof
#193Piperidinone carboxamide azaindane CGRP receptor antagonists
#194Spiro-oxindole MDM2 antagonists
#195Heterocyclic acrylamides and their use as pharmaceuticals
#196Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
#197Substituted pyridine derivatives as FabI inhibitors
#198MK2 inhibitors
#199Tetrahydropyridine derivatives as FabI inhibitors
#200CGRP RECEPTOR ANTAGONISTS
#201Compounds for electronic devices
#202Spirocyclic morphinans and their use
#203Metabotrophic glutamate receptor 5 modulators and methods of use thereof
#204Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#205BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS
#206Isoindolinone inhibitors of phosphatidylinositol 3-kinase
#207Inhibitors of the renal outer medullary potassium channel
#208Inhibitors of leukotriene production
#209Substituted tricyclic compounds as FGFR inhibitors
#210Synthesis of [2.2.2]-diazabicyclic ring systems
#211Fused heterocyclic azaindane carboxamide CGRP receptor antagonists
#212Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
#213Dispiropyrrolidine derivatives
#214CGRP Receptor Antagonists
#215Bridged triarylamines and -phosphines as materials for electronic devices
#216Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#217Heterocyclic acrylamides and their use as pharmaceuticals
#218Spiroimidazolone derivative
#219DISPIROPYRROLIDINE DERIVATIVES
#220AUTOPHAGY INDUCING COMPOUND AND THE USES THEREOF
#221MK2 inhibitors
#222POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY
#223Isoindolinone inhibitors of phosphatidylinositol 3-kinase
#224Substituted piperazines as CGRP antagonists
#225Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
#226Piperidinone carboxamide azaindane CGRP receptor antagonists
#227Piperidinone carboxamide azaindane CGRP receptor antagonists
#228Piperidinone carboxamide azaindane CGRP receptor antagonists
#229RADIOLABELED CGRP ANTAGONISTS
#230Process for the stereoselective preparation of bicyclic heterocycles
#231N1/N2-lactam acetyl-CoA carboxylase inhibitors
#232DERIVATIVES OF 10-AMINO-1,2,3,4-TETRAHYDROPYRIDO[2,1-A]ISOINDOL-6(10BH)-ONES, METHOD FOR PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
#233BENZAZEPINE COMPOUNDS AS CGRP RECEPTOR ANTAGONISTS
#234ISOINDOLINONE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE
#235Tetracyclic Lactame Derivatives
#236CGRP receptor antagonists
#237Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof
#238IMIDAZOLINONE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
#2393- and 6-quinolines with N-attached heterocyclic CGRP receptor antagonists
#240Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
#241NMDA Receptor Modulators and Uses Thereof
#242SPIRO (FURO [3, 2-C] PYRIDINE-3-3' -INDOL) -2' (1'H)-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF SODIUM-CHANNEL MEDIATED DISEASES, SUCH AS PAIN
#243Organic compounds
#244CGRP receptor antagonists
#245Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives
#246CYCLOHEXYL AMIDE DERIVATIVES AS CRF RECEPTOR ANTAGONISTS
#247Non-amidic linkers with branched termini as CGRP receptor antagonists
#248Spiroazaindoles
#249Spiro-oxindole MDM2 antagonists
#250Branched 3- and 6-substituted quinolines as CGRP receptors antagonists
#251N-ARYL DIAZASPIROCYCLIC COMPOUNDS AND METHODS OF PREPARATION AND USE THEREOF
#252Spirotropane compounds
#253Tricyclic tetrahydroquinoline antibacterial agents
#254SPIRODIAMINE-DIARYL KETOXIME DERIVATIVE
#255METHOD OF MAKING IMIDAZOAZEPINONE COMPOUNDS
#256Monocyclic CGRP receptor antagonists
#257Compounds
#258Inhibitors of the chemokine receptor CxCR3
#259Carboxamide heterocyclic CGRP receptor antagonists
#260SPIRO (FURO [3, 2-C] PYRIDINE-3-3' -INDOL) -2' (1'H)-ONE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF SODIUM-CHANNEL MEDIATED DISEASES, SUCH AS PAIN
#261Monocyclic anilide spirolactam CGRP receptor antagonists
#262Pyrazine-2-carboxamide derivatives to treat diseases mediated by blockade of the epithelial sodium channel
#263Aryl heterocyclic CGRP receptor antagonists
#264CGRP RECEPTOR ANTAGONISTS
#265Bicyclic anilide heterocyclic CGRP receptor antagonists
#266Method for synthesis of nitroxyl radical
#267Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
#268Substituted monocyclic CGRP receptor antagonists
#269Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease
#270TRICYCLIC TETRAHYDROQUINOLINE ANTIBACTERIAL AGENTS
#271Spirolactam bicyclic CGRP receptor antagonists
#272Organic compounds
#273Spirolactam aryl CGRP receptor antagonists
#274IMIDAZOAZEPINONE COMPOUNDS
#275Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity
#276Heterocyclic spiro-compounds as aldosterone synthase inhibitors
#277Tetracyclic lactame derivatives
#278Tricyclic Spiro Compound Comprising Acyl Group Bound to Nitrogen Atom in the Ring
#279Substituted monocyclic CGRP receptor antagonists
#280Spiroindolinone derivatives
#281N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
#282SPIROINDOLINONE DERIVATIVES
#283CGRP receptor antagonists
#284Substituted monocyclic CGRP receptor antagonists
#285Tricyclic tetrahydroquinoline antibacterial agents
#286CXCR3 antagonists
#287Spiropiperidine derivatives for controlling pests
#288Physiologically active substances PF1270A, B and C substances
#289Novel spiro-quinuclidinyl derivatives for the treatment of central nervous system disorders
#290New compounds
#291N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
#292Spiroheterocyclic derivative compounds and drugs comprising the compound as the active ingredient
#293Beta-carbolines as growth hormone secretagogue receptor (GHSR) antagonists
#294N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
#295Tetrahydroisoquinoline or isochroman compounds
#296Tricyclic compound having spiro union
#297Compounds useful as motilin agonists and method
#298Cyclopentyl modulators of chemokine receptor activity
#299Compounds useful as motilin agonists and method
#300Antihistaminic spiro compounds